Citing Article List

The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of “Anti-PD-1/L1 antibody plus anti-VEGF antibody vs. plus VEGFR-targeted TKI as first-line therapy for unresectable hepatocellular carcinoma: a network meta-analysis”.

No.

Publication Date

Citing Article

1

2025

Jing Xu, Xin Wang, Zhenya Jia, Guoping Sun. Effectiveness and safety of angiogenesis inhibitors combined with PD-1/PD-L1 blockades in the first-line treatment of patients with advanced hepatocellular carcinoma: A single-center retrospective study, Medicine. 2025; 104: e41814.  https://doi.org/10.1097/MD.0000000000041814

2

2025

V. A. Valishin, K. V. Menshikov, A. V. Sultanbaev, R. R. Abdeev, R. R. Urazin, Sh. I. Musin, L. A. Valishina, V. I. Zgonikov, R. T. Ayupov, I. N. Startsev-Svetlichny. Conversion therapy for hepatocellular carcinoma: a case report, Siberian journal of oncology. 2025; 24: 170.  https://doi.org/10.21294/1814-4861-2025-24-4-170-177

3

2025

Qing Bao, Haoming Chen, Song Wu, Zhi Tian, Hailin Tang. Role of immune checkpoint inhibitors in breast cancer and hematological malignancies, Exploration of Immunology. 2025; 5: 1003220.  https://doi.org/10.37349/ei.2025.1003220